Kinvard Bio Revenue

Biotechnology Research • Raleigh, North Carolina, United States • 1-10 Employees

Kinvard Bio revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$2,000,000
Total funding	$3,900,000

Key Contacts at Kinvard Bio

Paul Garofolo

Member Board Of Directors

Nathan Finger

Director Of Operations

Kelvin Wu

Director Of Platform Development

Company overview

Headquarters	Raleigh, North Carolina, United States
Website	kinvardbio.com
NAICS	541714
Founded	2024
Employees	1-10

Kinvard Bio Email Formats

Kinvard Bio uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@kinvardbio.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@kinvardbio.com	100%

About Kinvard Bio

Kinvard Bio is committed to developing a new, highly differentiated class of ribosome-targeting antibiotics to treat the most challenging acute and chronic drug-resistant bacterial infections. Our chemistry platform technology is based on groundbreaking research that has been exclusively licensed from the Myers lab in the Department of Chemistry and Chemical Biology at Harvard University and funded by the Kineticos AMR Accelerator Fund I (KAMRA I). The oxepanoprolinamides (OPPs) represent a distinct class of lincosamide antibiotics that are pre-organized for highly effective and differentiated binding to the bacterial ribosome. In preclinical studies, OPPs have proven effective against both Gram-positive and Gram-negative bacterial pathogens associated with high unmet clinical need and commercial potential.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Director

Vice President

Funding Data

Explore Kinvard Bio's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2025-03-24	2	N/A
2025-03-24	3	$1,200,000
2025-08-29	9	$2,700,000

Funding Insights

$3,900,000

Total funding amount

$2,700,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

Kinvard Bio is located in Raleigh, North Carolina, US.

Kinvard Bio generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Kinvard Bio has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Kinvard Bio was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Kinvard Bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Kinvard Bio has raised a total of $3,900,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.